| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.066 | 0.6 |